Selected research
Industry Research
Equine Rabies Immunoglobulin (ERIG) Industry Research Report 2026
Market perspective
The global Equine Rabies Immunoglobulin (ERIG) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Equine Rabies Immunoglobulin (ERIG) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Equine Rabies Immunoglobulin (ERIG) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Equine Rabies Immunoglobulin (ERIG) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Equine Rabies Immunoglobulin (ERIG) include Wuhan Institute of Biological Products, Serum China, Lanzhou Institute of Biological Products, Premium Serums, Haffkine Bio-Pharmaceutical and Bharat Serums, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Equine Rabies Immunoglobulin (ERIG) market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Equine Rabies Immunoglobulin (ERIG) Market by Company
Wuhan Institute of Biological Products
Serum China
Lanzhou Institute of Biological Products
Premium Serums
Haffkine Bio-Pharmaceutical
Bharat Serums
Equine Rabies Immunoglobulin (ERIG) Segment by Type
1500IU
1000IU
400IU
Other
Equine Rabies Immunoglobulin (ERIG) Segment by Application
Category II Exposure
Category III Exposure
Equine Rabies Immunoglobulin (ERIG) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Equine Rabies Immunoglobulin (ERIG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Equine Rabies Immunoglobulin (ERIG) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Equine Rabies Immunoglobulin (ERIG).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Equine Rabies Immunoglobulin (ERIG) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Equine Rabies Immunoglobulin (ERIG) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Equine Rabies Immunoglobulin (ERIG) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1500IU
- 1000IU
- 400IU
- Other
Applications
- Category II Exposure
- Category III Exposure
Companies covered
- Wuhan Institute of Biological Products
- Serum China
- Lanzhou Institute of Biological Products
- Premium Serums
- Haffkine Bio-Pharmaceutical
- Bharat Serums
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size (2021-2032)
- 2.2.2 Global Equine Rabies Immunoglobulin (ERIG) Sales (2021-2032)
- 2.2.3 Global Equine Rabies Immunoglobulin (ERIG) Market Average Price (2021-2032)
- 2.3 Equine Rabies Immunoglobulin (ERIG) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1500IU
- 2.3.3 1000IU
- 2.3.4 400IU
- 2.3.5 Other
- 2.4 Equine Rabies Immunoglobulin (ERIG) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Category II Exposure
- 2.4.3 Category III Exposure
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Equine Rabies Immunoglobulin (ERIG) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Equine Rabies Immunoglobulin (ERIG) Sales (K Tons) of Manufacturers (2021-2026)
- 3.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue of Manufacturers (2021-2026)
- 3.4 Global Equine Rabies Immunoglobulin (ERIG) Average Price by Manufacturers (2021-2026)
- 3.5 Global Equine Rabies Immunoglobulin (ERIG) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Equine Rabies Immunoglobulin (ERIG), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Equine Rabies Immunoglobulin (ERIG), Product Type & Application
- 3.8 Global Manufacturers of Equine Rabies Immunoglobulin (ERIG), Established Date
- 3.9 Global Equine Rabies Immunoglobulin (ERIG) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wuhan Institute of Biological Products
- 4.1.1 Wuhan Institute of Biological Products Company Information
- 4.1.2 Wuhan Institute of Biological Products Business Overview
- 4.1.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolio
- 4.1.5 Wuhan Institute of Biological Products Recent Developments
- 4.2 Serum China
- 4.2.1 Serum China Company Information
- 4.2.2 Serum China Business Overview
- 4.2.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Serum China Equine Rabies Immunoglobulin (ERIG) Product Portfolio
- 4.2.5 Serum China Recent Developments
- 4.3 Lanzhou Institute of Biological Products
- 4.3.1 Lanzhou Institute of Biological Products Company Information
- 4.3.2 Lanzhou Institute of Biological Products Business Overview
- 4.3.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolio
- 4.3.5 Lanzhou Institute of Biological Products Recent Developments
- 4.4 Premium Serums
- 4.4.1 Premium Serums Company Information
- 4.4.2 Premium Serums Business Overview
- 4.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolio
- 4.4.5 Premium Serums Recent Developments
- 4.5 Haffkine Bio-Pharmaceutical
- 4.5.1 Haffkine Bio-Pharmaceutical Company Information
- 4.5.2 Haffkine Bio-Pharmaceutical Business Overview
- 4.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Portfolio
- 4.5.5 Haffkine Bio-Pharmaceutical Recent Developments
- 4.6 Bharat Serums
- 4.6.1 Bharat Serums Company Information
- 4.6.2 Bharat Serums Business Overview
- 4.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolio
- 4.6.5 Bharat Serums Recent Developments
5 Global Equine Rabies Immunoglobulin (ERIG) Market Scenario by Region
- 5.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region: 2021-2032
- 5.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region: 2021-2026
- 5.2.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region: 2027-2032
- 5.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2021-2032
- 5.3.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2021-2026
- 5.3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2027-2032
- 5.4 North America Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
- 5.4.1 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2032)
- 5.4.3 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
- 5.5.1 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2032)
- 5.5.3 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
- 5.7.1 South America Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2032)
- 5.7.3 South America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2032)
- 6.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2032) & (K Tons)
- 6.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2021-2032)
- 6.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2021-2032)
- 6.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2021-2032)
- 6.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2032)
- 7.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2032) & (K Tons)
- 7.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2021-2032)
- 7.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2021-2032)
- 7.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2021-2032)
- 7.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Equine Rabies Immunoglobulin (ERIG) Value Chain Analysis
- 8.1.1 Equine Rabies Immunoglobulin (ERIG) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Equine Rabies Immunoglobulin (ERIG) Production Mode & Process
- 8.2 Equine Rabies Immunoglobulin (ERIG) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Equine Rabies Immunoglobulin (ERIG) Distributors
- 8.2.3 Equine Rabies Immunoglobulin (ERIG) Customers
9 Global Equine Rabies Immunoglobulin (ERIG) Analyzing Market Dynamics
- 9.1 Equine Rabies Immunoglobulin (ERIG) Industry Trends
- 9.2 Equine Rabies Immunoglobulin (ERIG) Industry Drivers
- 9.3 Equine Rabies Immunoglobulin (ERIG) Industry Opportunities and Challenges
- 9.4 Equine Rabies Immunoglobulin (ERIG) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst